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Abstract
We study the dynamics of poverty and health in a model of endogenous growth and ra-
tional health behavior. Population health depends on the prevalence of infectious diseases
that can be avoided through costly prevention. The incentive to do so comes from the nega-
tive effects of ill health on the quality and quantity of life. The model can generate a poverty
trap where infectious diseases cycle between high and low prevalence. These cycles origi-
nate from the rationality of preventive behavior in contrast to the predator-prey dynamics
of epidemiological models. We calibrate the model to reflect sub-Saharan Africa’s recent
economic recovery and analyze policy alternatives. Unconditional transfers are found to
improve welfare relative to conditional health-based transfers: at low income levels, income
growth (quality of life) is valued more than improvements to health (quantity of life).
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1 Introduction
Health and income are each elemental to welfare but it is perhaps their joint relationship that
has most intrigued researchers. Countries that are poor are also likely to have worse popula-
tion health. Nowhere is this correlation more apparent than in sub-Saharan Africa with its twin
problems of severe poverty and ill health. Much of the ill health stems from infectious diseases
which account for 64% of its overall disease burden (DALYs) relative to 30% worldwide (Global
Burden of Disease 2002, WHO). While the burden falls disproportionately on infants and chil-
dren, adults suffer too. The probability of death between ages 15 and 60 is 30%−60% for African
men compared to less than 12% in developed countries (Rajaratnam et al., 2010).
Building on prior work, Chakraborty et al. (2010), this paper presents a simple dynamic
model of poverty and health. In a two period OLG model of endogenous growth, health is the
outcome of exposure to infections early in life. That exposure depends on the prevalence of
infectious disease and the extent to which individuals take preventive action to avoid them.
Prevention incentives depend on the economic cost of illness and the effect of illness on overall
wellbeing, while the ability to undertake costly prevention depends on potential earning.
This paper makes two new contributions to the literature on health and development. First
it shows that the complementarity between poverty and infection risk can lead to a unique
poverty trap that consists of periodic health and economic cycles. Epidemiological models are
known to admit cycles, usually from some form of predator-prey interaction. Cycles arise here,
instead, from a behavioral response to the threat of infection and the effect of that infection on
household choices and income.
An economy suffering from poverty and ill health faces a low return from costly prevention
since the threat of infection – the disease externality – is high. Despite an underinvestment in
prevention and its concomitant ill health, as long as aggregate TFP is high enough, the economy
grows incrementally. When income crosses a threshold, prevention becomes affordable. This
has two effects: it leaves fewer resources towards investments that directly augment future in-
come and it lowers the aggregate risk of infection. The first effect depresses the future economy,
the latter reduces incentives to engage in further prevention. The combined effect is to tip the
economy back towards high disease prevalence.
The second contribution of this paper is to inform policies that facilitate economic and
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health transitions.1 After decades of stagnation during which African growth hovered at a dis-
mal 1% in real terms and population health problems intensified, there are signs of hope for the
continent. GDP per capita grew by 5% during the last three years (IMF, 2013) and the HIV crisis
has stabilized, on the retreat in some areas (UN, 2013).
Inspired by this incipient growth, we calibrate the model to replicate broad patterns of sub-
Saharan Africa’s development. The dynamics implied by this exercise show slow initial growth
and health improvement that then lead to rapid convergence towards the growth frontier. We
study several types of policies – unconditional foreign aid, conditional (health-based) foreign
aid and domestic transfers. Much of the debate on the effectiveness of foreign aid and poverty
alleviation has occurred in a theoretical vacuum, without close attention to the intertemporal
nature of poverty and its incentives. Since ill health is the source of poverty in our theory of
African underdevelopment, the model is particularly suited to identify the dynamic gains and
losses from these policy alternatives.
We show that, in principle, foreign assistance can be an effective tool to improve health and
economic outcomes.2 Both conditional and unconditional foreign aid are capable of signifi-
cantly improving health and income though, somewhat surprisingly, unconditional aid is better
at improving overall welfare. Even though health-based aid is better at effecting a health transi-
tion, at low levels of income, those gains to the quantity of life are dominated by the higher value
placed on the faster income gains from unconditional aid. We also consider combination poli-
cies that ease the economy into transition through foreign aid, later replaced by fully-funded
domestic transfers: the welfare gains relative to the non-interventionist outcome are sizable,
but come at the cost of slow convergence to the growth frontier.
Several bodies of work are related to this paper. We build on Geoffard and Philipson’s (1996)
insight that ignoring the effect of rational health behavior may convey an imprecise view of
disease dynamics and the effectiveness of public health interventions. Two contributions in
economic epidemiology most relevant for our work are Goenka and Liu (2010) and Goenka et al.
(2013). Both integrate the susceptible-infectious-susceptible (SIS) model from epidemiology
1By health transition we mean not just an epidemiological transition out of infectious diseases but behavioral
changes accompanying that transition, specifically the adoption of preventive health (Frenk et al. 1991).
2This is not to deny the problems of implementation, time inconsistency and institutional failures that have
plagued aid effectiveness. Since most models of poverty are either static or purely income-based, the value added
of our exercise lies in identifying policies that are better at improving dynamic incentives and quantifying their
human and economic costs.
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into dynamic general equilibrium models. The first paper illustrates the presence of disease
and economic cycles due to a variation of the predatory-prey mechanism where there is no
health choice. The second paper incorporates public health expenditure that affects people’s
susceptibility to illness and recovery from it and establishes a rich set of dynamic possibilities
for the social planner’s problem. In our paper, on the other hand, market failures from disease
and production externalities drive the dynamics and open the door for policy interventions.3
From the voluminous literature on foreign aid and growth, one paper is particularly rele-
vant to our analysis of conditional health-based aid. Mishra and Newhouse (2009) estimate
the effects of aid on infant mortality and find that although overall foreign aid does not have a
statistically significant effect on infant mortality, health aid does. On developing country epi-
demiology, García-Montalvo and Reynal-Querol (2007) find that forced migration and social
disruption due to civil wars are significant contributors to malaria incidence. While we ignore
geo-political factors in the spread of diseases, if the quantitative results presented here are any
indication, the cumulative economic cost of this interaction between conflict and health is siz-
able.
A third literature related to our work studies the effectiveness of in-kind and cash trans-
fers for poverty alleviation. Economists have traditionally preferred the use of cash transfers
over in-kind transfers since the latter can lower overall utility by restricting household choices
(Currie and Gahvari, 2008). Yet one of the key aspects of poverty is its dynamic nature. In fact
if poverty were a transitional problem, the need for pro-poor policies would be less pressing.
When dynamic incentives matter, in-kind transfers may well be more effective if they are tar-
geted towards investments that improve income in the long run (Mookherjee, 2006). To the
best of our knowledge this paper is the first to formalize this tradeoff in the context of Africa
and poverty stemming from infectious disease and ill health.
The remainder of the paper is organized as follows. Section 2 reviews the model and identi-
fies the key forces driving the dynamics of health and development. The model is calibrated to
sub-Saharan Africa (henceforth SSA) in section 3 which then presents convergence dynamics
and poverty trap cycles for reasonable parameter values. Section 4 returns to the baseline case
of convergence growth and studies various policy packages. Section 5 concludes.
3While Goenka et al. (2013) focus on steady states of their planner’s problem, it is possible that their model too
admits cycles since it embeds a similar behavioral response to disease prevalence.
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2 The Model
Overlapping generations of families populate a discrete time, infinite horizon economy. At ev-
ery date t = 1,2, . . . a unit mass of individuals is born. They are each endowed with a unit of labor
time and potentially live for two periods. Survival to the second period depends on whether or
not they contract infectious disease early in life and prematurely die from it. Model particulars
closely follow Chakraborty et al. (2010), henceforth CPP (2010).
2.1 Disease Transmission
Individuals work in youth and are retired in the second period. During youth, each individual
gives birth to one offspring who is born healthy. An infected adult suffers a productivity loss of
θ due to morbidity, supplying 1−θ units of efficiency labor. He also enjoys a lower quality of life:
a consumption bundle c delivers the utility flow δu(c) instead of u(c), where δ ∈ (0,1). Finally,
an infected young individual faces the risk of dying before reaching old age.
All individuals start their youth being healthy. Subsequently some of them contract infec-
tious diseases, susceptibility to which depends on prevention and disease prevalence. Early in
youth individuals undertake preventive investment xt ≥ 0. This can take the form of expen-
ditures on food and medicine to improve general health, or specific actions like investing in
cleaner environment (e.g., potable water, sanitation), protective goods (e.g., mosquito nets,
condoms) and occupational shift (e.g., more hospitable farmland). Prevention is chosen ex
ante, before a susceptible young individual is exposed to infections, funded by zero-interest
within-period borrowing against labor income.
Diseases spread from infected to susceptible individuals either directly via humans or in-
directly through vectors such as mosquitoes, tsetse flies, water and air. Since our objective is
to model the transmission of various infectious diseases generally, we take a parsimonious ap-
proach is assuming that the microbial load among these disease vectors is simply proportional
to the number of infected individuals and that each susceptible individual is exposed to µ > 1
types of disease vectors.4 Given xt , the probability that a young individual gets infected from a
particular disease vector is
pi(x)= a
1+qx , a ∈ (0,1), a > 1/µ, q > 0, (1)
4For an alternative specification of intra- and inter-cohort human-to-human transmission, see CPP (2010).
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for which pi′ < 0, pi(0)= a and pi(∞)= 0.
The assumptions underlying (1) merit further discussion. The parameter a should be thought
of as intrinsic resistance, the outcome of virus mutations and genetic evolution of humans in
their particular environment. Humans in the Old World acquired immunity and resistance over
thousands of years as a consequence of its temperate climate and domestication of animals,
endowing those populations with lower values of a that increased the efficacy of preventive be-
havior. For example, starting from a population with heterogenous disease resistance, if less
resistant individuals died without passing on their genes, over time the population would end
up with lower average a.
In the case of SSA this evolutionary process may have been confounded by its encounter
with the West. Colonization introduced new diseases to non-immune populations in eastern,
central, and southern Africa that were relatively more isolated than western Africa. Previously
endemic diseases often took the form of epidemics so much so that the period 1880− 1920
has been described as a time of tumultuous “ecological disaster” (Lyons 1993). By the mid-
nineteenth century, tropical Africans were afflicted by most of the diseases of the temperate
Old World.
Similarly we interpret q as the effectiveness of medicine and national health institutions.
These are taken as exogenous (see Bhattacharya et al., 2007, for a model of public health). The
epidemiological literature offers evidence why q may have been substantially lower in Africa
than in Europe. If colonialism brought new diseases to Africa, public health practices of the
colonial powers did not help matters. Often large-scale medical campaigns were launched
against single illnesses which were expensive but made little dent on the overall problem. In
some cases, disease-specific knowledge was either absent or had limited transferability to Africa
(Dunn, 1993). These problems have been worsened in the twentieth century by wars and so-
cial unrest, and by public health systems that are widely ineffective due to corruption, lack of
provision and, in some cases, scarcity of skilled manpower.
Let pt denote the probability of being infected for a typical young member of generation t .
The probability that this person contracts an infection from exposure to a specific vector is itpit ,
where it is microbial load, proportional to the fraction of generation t −1 who were infected.
Hence the probability of contracting infections from exposure to the µ disease vectors is
pt = 1− [1− itpi(xt )]µ. (2)
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Appealing to the law of large numbers, this gives the prevalence rate of the disease at date t +1,
that is, it+1 = pt .
Our transmission process departs in important ways from the epidemiology literature where
the evolution of diseases is typically exogenous to human decisions. Although the way infec-
tion spreads from the infective to the susceptible population in equation (2) is akin to standard
epidemiological models, the probability of that transmission depends on a cost-benefit calcu-
lation of whether or not prevention is desired. We show later that the willingness to undertake
prevention depends discontinuously on disease prevalence and income. Households are un-
willing to spend on prevention under two situations: when the prevalence rate is too low and
the threat of infection negligible, or when the prevalence rate is so high that the disease exter-
nality trumps private health behavior. Because of this, we streamline the disease dynamics in
other respects relative to epidemiological models.
2.2 Preferences and Prevention
As Figure 1 illustrates, household behavior is best studied in two stages: first, economic choices
are made contingent on prevention and disease outcomes, then health choices determine the
risk of infections and economic outcomes. Let the superscript U (I ) on variables denote de-
cisions and outcomes for uninfected (infected) individuals. An uninfected individual whose
preventive behavior has successfully protected him from infectious disease maximizes lifetime
utility
u
(
cU1t
)+βu (cU2t+1) , β ∈ (0,1)
subject to the budget constraints cU1t = wt − xt − zUt and cU2t+1 = Rt+1zUt , w being the wage per
efficiency unit of labor, z denotes savings and x is given by decisions made early in period t .
An infected individual, facing the constant probability 1−φ ∈ [0,1] of dying from infectious
disease in old-age, maximizes expected lifetime utility
δ
[
u
(
c I1t
)+βφu (c I2t+1)]
subject to c I1t = (1−θ)wt − xt − z It and c I2t+1 = Rˆt+1z It , where Rˆt+1 denotes the annuity return
that the individual takes as given. Assuming a perfect annuities market, in equilibrium, we
have Rˆt+1 =Rt+1/φ. For the utility function, we choose the standard CES, u(c)=
(
c1−σ−1)/(1−
σ), σ≥ 0.
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Generation-t born 
Invests in 
preventive health 
care xt, given it 
Exposed to disease 
vectors, contracts 
disease with 
probability pt 
Supplies efficiency labor to 
final goods producing firms, 
earns wages, makes 
consumption-saving 
decisions, gives birth to a 
single offspring 
Newborns infected with 
probability pt+1 
Infected individuals 
experience mortality shock, 
fraction 1 - ϕ of them die 
Surviving members of 
generation t consume 
and subsequently die 
t t + 1 t + 2 
Figure 1: Timing of Events
Conditional on the choice of x, the household’s optimization problem yields the saving de-
cisions
zUt = sUt (wt −xt ), with sUt ≡
(
β1/σR1/σ−1t+1
1+β1/σR1/σ−1t+1
)
, and (3)
z It = s It [(1−θ)wt −xt ], with s It ≡
[
φβ1/σR1/σ−1t+1
1+φβ1/σR1/σ−1t+1
]
(4)
where the equilibrium annuity return has been substituted in. The impact of disease on devel-
opment partly follows from the result zUt > z It . The infected save less since they face a shorter
lifespan (φ< 1) and are less productive (θ > 0). The third type of cost, a lower utility flow (δ< 1),
affects saving indirectly through preventive investment.
Turn to this decision next. Substituting (3) and (4) into lifetime utility gives the two indirect
utility functionsVU (xt ) andV I (xt ) contingent on prices, preventive health choices and disease
realizations. At the beginning of their youth, forward-looking individuals choose xt to maximize
expected lifetime utility
Vt ≡ ptV I (xt )+
(
1−pt
)
VU (xt ) (5)
subject to xt ≥ 0 and equation (2), that is, taking into account how xt alters their risk of con-
tracting infections. If the marginal cost from health investment exceeds the marginal benefit at
xt = 0, no-prevention is an optimal choice.
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2.3 Production Technology
Define Lt = 1− θpt as the aggregate efficiency labor supply at time t , and kt = Kt/Lt as the
capital stock (K ) per effective unit of labor. A continuum of firms, indexed by i , operate in
perfectly competitive markets to produce the final good using capital and labor. For firm i , the
production function is:
F (K i ,Li )= A
(
K i
)α (
k¯Li
)1−α
, (6)
whereα ∈ (0,1), A > 0 is a constant productivity parameter, k¯ denotes the average capital inten-
sity across firms and it augments labor productivity through a learning-by-doing externality.
Standard factor pricing relationships under such externalities imply that the wage per effective
unit of labor (wt ) and interest factor (Rt ) are wt = (1−α)Akt , and Rt =αA ≡R, respectively.
2.4 Equilibrium Dynamics
The solution to the maximization problem (5) defines optimal prevention as a function of capi-
tal per effective worker and disease prevalence, xt = x(kt , it ). Optimal prevention is zero as long
as its utility cost dominates. This occurs at relatively low levels of income and very high preva-
lence rates, or for very low prevalence rates. When people do engage in prevention, the demand
for prevention depends on the capital stock and disease prevalence in predictable ways, that is,
∂x/∂k > 0 and ∂x/∂i > 0.
Using optimal health investment x(kt , it ), the equilibrium probability of getting infected
can be written as pt = p (x(kt , it ), it ) ≡ p(kt , it ). For reasonable numerical values assigned to
the parameters, including the ones we use later, ∂pt/∂kt < 0 and ∂pt/∂it > 0. The former result
is simply an income effect operating through prevention. The latter (∂pt/∂it > 0) is determined
by two opposing effects: disease prevalence directly increases the probability of contracting
infections but also tends to lower it by encouraging prevention. This indirect effect is not suffi-
ciently strong to overturn the externality effect.
Two difference equations fully characterize the global dynamics given the initial conditions
(k1, i1). To get the first one, observe that aggregate saving is St = pt z It + (1−pt )zUt and the asset
market clears when Kt+1 = St . Substituting for equilibrium disease transmission and dynamics,
this leads to
kt+1 = p(kt , it )z
I (kt , it )+ [1−p(kt , it )]zU (kt , it )
1−θp (p(kt , it )) . (7)
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The equilibrium evolution of the prevalence rate follows
it+1 = p(kt , it ). (8)
The non-linear difference equation system comprising of equations (7) and (8) can enter-
tain a surprisingly rich set of dynamic behavior. One possibility is two asymptotically stable sta-
tionary equilibria. In the better stationary equilibrium, a fully healthy population enjoys rapid
improvements in living standards.5 The worse stationary equilibrium, on the other hand, can
be of two types. In one type, the economy is in a poverty trap that exhibits monotonic conver-
gence: in the long run everyone is infected (at some point in their youth), there is no investment
in prevention and growth is low, even zero. Such a poverty trap may be “income neutral” in the
sense that exogenous (higher A) or endogenous increase in income do not take the economy of
the trap. This is the case analyzed in CPP (2010).
For future reference we derive these growth paths. Define γ to be the growth rate of the
economy’s capital stock per effective unit of labor in steady state. When i = 0, no one has to
invest in prevention and the economy-wide saving propensity is sU . Equation (7) then implies
the high growth path is
1+γH ≡ (1−α)AsU =
[
β1/σ(αA)1/σ−1
1+β1/σ(αA)1/σ−1
]
(1−α)A. (9)
We shall refer to this as a country’s potential long-run growth: whether or not it is attained
depends on the presence of other local attractors.
Now consider a steady-state with full prevalence i = 1. If prevention is ineffective in this
environment, no one would invest in it and everyone would suffer from ill health.6 If such a
steady-state exists and is asymptotically stable, the asymptotic growth factor is
1+γL ≡ (1−θ)(1−α)AsL =
[
φβ1/σ(αA)1/σ−1
1+φβ1/σ(αA)1/σ−1
]
(1−θ)(1−α)A. (10)
The growth rate is zero if the expression on the right is less than one, positive otherwise.
5The high-growth steady state always exists and is asymptotically stable: indeed it is the conventional steady-
state in an OLG model with Ak technology. The other stationary equilibrium may not be stable or may not exist.
6Since we are modeling various types of infections, many of them endemic, the full prevalence steady-state
should be viewed as one where the entire population suffers from one or more infectious diseases at some point in
youth. We adjust the mortality and morbidity cost of diseases in the calibration later to reflect this average lifetime
effect.
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Interestingly this is not the only type of asymptotically stable poverty trap that can arise.
Section 3 shows that for reasonable values of TFP and the elasticity of inter-temporal substitu-
tion (EIS), there can be poverty traps featuring periodic cycles in disease and development.
3 Quantitative Analysis
Among the growth facts development economists agree on is SSA’s post-WWII divergence from
the rest of the world: SSA’s output per worker grew at an average annual rate of 0.6% during
1950−2000 against 1.9% for the US (Penn World Table 6.2). The quantitative analysis calibrates
the model to fit these growth patterns as of 2000−01. As we will see later, the baseline model
will generate a dynamic path consistent with the signs of SSA’s economic recovery during the
last decade.
3.1 Calibration
Since our objective is to assess the macroeconomic effects of the infectious disease burden, in-
stead of calibrating the model to a specific disease as in CPP (2010), we use aggregate data on
mortality and morbidity in SSA whenever possible. That captures more appropriately the com-
plementarities across infectious diseases that simultaneously affect a population. For example,
one study estimates that the interaction between malaria and HIV may have been responsible
for 8,500 excess HIV infections and 980,000 excess malaria episodes in Kenya (Abu-Raddad et
al., 2006). Such co-infection may have also made it easier for malaria to spread to areas with
high HIV prevalence. Other studies have found that open sores from untreated bacterial STDs
in SSA facilitate the transmission of the HIV virus. The result of these complementarities is that
the overall economic loss due to mortality and morbidity is higher than the average loss across
illnesses.
Preference Production Health & Disease
β= 0.28 γH = 0.018 θ = 0.15 µ= 6000
σ= 1 α= 0.67 φ= 0.62 q = 35
A = 24.18 δ= 0.73 a = 0.2
Table 1: Benchmark Parameter Values
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Table 1 reports the assigned parameter values that we will refer to as the baseline scenario.
The model features overlapping generations of agents who potentially live for two periods. To
choose the length of one period, we use data on U.S. life expectancy at age 15 (LE15) which
was 63 in 2000 according to the World Health Statistics 2008. This implies 31.5 years for each
period or generation. Accordingly the discount factor β is calibrated to 0.9931.5×4 based on the
“standard” value per quarter.
We take preferences to be logarithmic,σ= 1. Later, we report robustness results forσ= 1.5.7
Two parameters need to be calibrated for the aggregate production function: the total factor
productivity (TFP) term A and the output elasticity of capital α. We interpret capital broadly
(physical, human, organizational) to setα= 0.67. The value for A is chosen such that the growth
rate is 1.8% in the potential high-growth steady state. This growth rate corresponds to OECD’s
average growth rate of GDP per capita during 1990− 2003 (UNDP 2005). In other words, A is
chosen such that (1−α)sU A = 1.01831.5, which implies A = 24.18.
This process of calibrating A may not be entirely appropriate for Africa. Besides technolo-
gies and institutions, A is affected by the ability of a country’s workforce. African soils are typ-
ically acidic, nitrogen-deficient and deprived of minerals like calcium and phosphorus (Kiple,
1993). As a result, crops have been lacking in protein and minerals. Since the sub-Saharan
African diet was predominantly vegetarian, it was thus nutrition-deficient. Animal protein was
relatively scarce: few animals were available because they were quickly hunted down or they fell
prey to illnesses from tsetse flies. Although some animals were raised in West Africa, there was a
taboo against drinking goat’s milk and eating eggs. Given current agricultural technologies and
specialization, these factors may plausibly affect Africa’s A through a lower labor productivity
even when the population is disease-free. We later study the effects of lowering A, hence γH .
Estimates of the quality-of-life effect come from disability weights in the Burden of Disease
Project. A disability weight for a specific disease is a scaling factor that ranges from zero (fully
healthy) to one (worst possible health state). It is derived from patient surveys on subjective
valuations of disease impact and varies according to illness. For example, it equals 0.0 for the
chagas disease, 0.1 for diarrheal episodes, 0.3 for malaria and 0.5 for AIDS according to WHO
(2008). The last three diseases account for much of SSA’s disease burden, so we take their aver-
age value and set δ= 1−0.27.
7These values are supported by available estimates. See, for example, Guvenen (2006).
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In order to obtain an estimate of the income loss due to morbidity, we look at Dasgupta
(1993). He finds that workers (in particular, farm workers) who are too ill to work in developing
countries lose about 15 to 20 days of work each year, and when they are at work, productivity
may be severely constrained by a combination of malnutrition and parasitic and other infec-
tious diseases. His estimates suggest that potential income loss due to illness for poor nations
are of the order of 15%. This is the value assigned to θ.
We calibrate the survival parameterφusing data from WHO (2001). According to this source,
fatalities from infectious diseases represent 38% of all deaths in Africa in 2001 for the adult male
population aged 45 to 80 – this interval corresponds to the agent’s second period of life when
they can die due to illness. We require that the model reproduce this number assuming that
SSA has very high prevalence, i ≈ 1. Since the entire population suffers from ill health under
full prevalence, the probability of death from infectious disease has to be 0.38. Hence φ= 0.62
is our benchmark value.
Parameters governing disease transmission (a, µ and q) are critical to quantifying the effort
needed to battle disease prevalence and transmission. Here we have less guidance from aggre-
gates. So we adopt estimates from CPP (2010) that focus on two diseases – malaria and AIDS –
that together accounted for 57% of all deaths in SSA from infectious diseases in 2001. They find
transmission probabilities in each encounter of malaria and HIV in the absence of prevention
are 25% and 1%, respectively; we choose an intermediate value of 0.2 for a. CPP also report
that sexual encounters amount to about 3,402 each model period per male and that a human
is bitten by a mosquito at least every 1.4 days. Given that the susceptibility to malaria declines
by 66% after 20 exposures, we set µ= 3402+31.5(1−0.66)365/1.4≈ 6000. Finally, CPP calibrate
values for q in the HIV and malaria cases of 1/0.0286= 35 and 1/0.0015= 667 respectively. We
adopt the smaller value assuming malaria (HIV) prevention does not make HIV (malaria) pre-
vention redundant. This holds for other infectious diseases as well: prevention is necessary for
all of them.
3.2 Convergence to the Growth Frontier
Using the baseline values from Table 1, we first present the model’s dynamics as it applies to
the “average” sub-Saharan African economy. We are also interested in understanding the dy-
namics more generally, that is, not narrowly restricted to the benchmark values. This we do by
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departing from Table 1 for key parameters.
Panel (a) of Figure 2 illustrates the phase portrait of the economy for the parameter values
in Table 1. It plots the prevalence rate it against the economy-wide stock of capital Kt .8 The
two x(Kt , it ) = 0 lines, in solid grey, represent combinations of (Kt , it ) for which the optimal
decision is not to invest in prevention. For low levels of disease prevalence (it → 0), the risk of
catching an infection is so low that prevention is not necessary. This is given by the lower piece
of the xt = 0 locus. At high levels of disease prevalence (it → 1), in contrast, the productivity of
prevention becomes so small at low levels of capital that prevention is not worthwhile. This is
given by the upper piece of the xt = 0 locus.
Turn next to the downward sloping locus, in dashed grey, it+1 = it . This is defined by it =
p(Kt , it ) along which prevalence remains constant. The locus is defined wherever xt > 0. In this
area, prevalence is always decreasing above the locus, increasing below it. When prevention is
zero, on the other hand, the prevalence rate is always increasing since µa > 1.
Finally turn to the dynamics of the capital stock. Capital remains constant along the Kt+1 =
Kt locus. As long as xt > 0, the capital stock declines above this locus and increases below. This
is because when prevention is positive, the capacity to save diminishes and if Kt is too small
and it sufficiently large, ∆Kt < 0. When x = 0, on the other hand, saving is always large enough
to keep capital increasing as long as K1 > 0.
The vector field generates three stationary equilibria, two of which are stable. The point la-
beled “unstable” on Figure 2(a) is a saddle-point which, since the initial conditions (K1, i1) are
pre-determined, is asymptotically unstable. One of the asymptotically stable stationary equi-
librium is the high-growth path labeledBGP along which infectious diseases are eradicated and
the economy grows at a healthy rate given by (9). Suppose that inspired by SSA’s recent signs
of recovery, we choose this initial state to be (K1, i1) = (14,1) which generates a growth recov-
ery and eventual convergence to the high-growth path even when the disease burden is high.
Figure 2(b) illustrates the trajectory of this economy: output per worker yt (equivalently aggre-
gate output) in black and the prevalence rate it in grey. Growth is initially negative – the disease
burden is too high to maintain a growing capital stock – but the economy keeps investing in pre-
vention. As population health improves, the economy gradually converges to an annual growth
8This is for ease of exposition. Capital per effective worker, k, can take the same value in two successive periods
even when aggregate capital, K , is being accumulated if there are fewer infected people. A phase portrait in (K , i )
space better distinguishes the partial equilibrium economic effects from the general equilibrium health effects.
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(c) Poverty Trap Cycle
Figure 2: Dynamics for the Baseline Model
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rate of 1.8%. By the ninth generation, output growth exceeds 50% of the long-run potential.
The other stationary equilibrium of this economy is a poverty trap, one characterized by ir-
regular 5-6 period cycles. If the economy were slightly poorer, (K1, i1) = (12,1), after an initial
period of economic contraction and falling prevalence, it converges to irregular periodic cycles.
The entire trajectory is illustrated in Figure 2(a) and the associated cycles (after convergence)
in Figure 2(c). This possibility of health cycles, disease cycles accompanied by changing preva-
lence behavior, is what distinguishes our poverty trap from the one in CPP (2010).
3.3 Health Cycles in a Poverty Trap
The existence of health cycles is robust to alternative parameter values. Maintaining the dis-
ease cost parameters at their benchmark values, for expositional convenience, we change two
parameters, the inverse of the EIS σ and total factor productivity A.
Since available estimates of the EIS are 1 or above, consider first the case of σ = 1.5. As
before we calibrate A to match the OECD growth rate which now implies a value A = 43.32.
Starting from the same initial conditions (K1, i1) = (14,1), Figure 3(a) shows that the economy
initially grows at negative rates for reasons similar to before. By the third generation health has
sufficiently improved that the economy steadily grows towards the high growth path. Here too,
the higher growth path is the unique asymptotically stable steady state.
Suppose, however, we delink the calibration of A from OECD growth for reasons alluded to
earlier. Instead of an annual growth rate of 1.8%, suppose that γH corresponds to an annual
growth rate of 1.5%. Over the course of a generation, such an economy would improve by 60%
as opposed to 75% before, a sizable welfare gap. For this lower growth rate, the value of A is 37.4
when σ= 1.5. Figure 3(b) shows that this economy never converges to the high growth path. It
cycles regularly between periods of high output per worker accompanied by better population
health, and low output accompanied by worse health.
Figure 4 illustrates cyclical poverty traps for other values of (A,σ). In the top two panels, the
EIS is slightly below 1 and potential long-run growth is quite high for the average sub-Saharan
African economy. Panel (a) shows a regular cycle of periodicity 9, panel (b) an irregular cycle of
4-7 periods. Panel (c) below returns to the baseline logarithmic case and shows irregular, 5-7
period, cycles for a slightly lower value of A. Recall that the saving rate is inversely related to the
interest factor, hence A, whenever σ > 1. To show that these cycles are not driven by low EIS,
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(a) A = 43.32, g = 1.8%
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(b) A = 37.4, g = 1.47%
Figure 3: Sustained Growth and Poverty Trap Cycles under σ= 1.5
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(a) σ= 1.1,A = 24.18,g = 1.45%
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(b) σ= 1.1,A = 25.5,g = 1.61%
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(c) σ= 1,A = 23.25,g = 1.67%
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(d) σ= 0.8,A = 15,g = 1.59%
Figure 4: Regular and Irregular Cycles
the last panel of Figure 4 shows irregular cycles of 9-10 periods for σ= 0.8.
Taken together these results show that it is easy for a poor economy with high disease bur-
den to remain in a poverty trap. This non-convergence result is similar to CPP (2010) even
though there were no cycles there.9 These cycles are not always frequent enough to be called
epidemics, so we prefer to think of them as long-run Malthusian dynamics in a world aware of
the cost and control of infectious disease. That a sharp reduction in prevalence can temporarily
depress per capita income mimics Young’s (2005) conjecture on the economic effect of AIDS,
though the mechanism is different.
It is not uncommon for epidemiology models to exhibit cycles. Cycles typically originate in
9There are two reasons for this difference. First, we assume a perfect annuities market here instead of the re-
distributive scheme in CPP (2010). This lowers the sensitivity of the saving propensity with respect to φ. Secondly,
calibrating φ to post-middle age infectious disease mortality alone implies a higher value. The combined effect is
to lower the economic cost of infectious disease and raise the saving propensity.
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those models from some form of predatory-prey dynamics, a tension between the population
of disease vectors and the population of susceptible humans. Consider specifically Goenka and
Liu (2010)’s interesting application of the SIS model to a Ramsey economy. There the disease
vectors are infective people while the susceptibles consist of healthy people who may have been
infected before and have now fully recovered. There is no health choice: individuals cannot af-
fect their susceptibility to or recovery from infections. Goenka and Liu (2010) show that cycles
depend on the contact and recovery rates. A high rate of contact between infective and sus-
ceptible agents implies high mobility from the susceptible to the infective states. At the same
time, if the recovery rate from infections is high, mobility from infective to susceptible states
is also high. This can generate cycles as a large percentage of the population moves from one
state to the other, that is, the relative size of the infectives (“predator”) and susceptibles (“prey”)
fluctuates. When the state of infection lowers labor income (similar to θ), infections causes the
economy to cycle, booms coinciding with an ebbing of the disease.
In contrast, the model here generates cycles through a different channel, closely linked to
the rationality of disease behavior. To understand the mechanics, it is useful to think of two
opposing forces: the positive (negative) effect of income (prevalence) on disease prevention,
and the negative effect of prevalence on the growth of output per worker via savings behavior.
The former depends on the disease transmission function pi whose parameterization does not
change in the experiments presented above. What does change is the latter and it changes due
to (σ,A), not the disease cost parameters (φ,δ,θ).
In every instance of cycles presented in Figures 3 and 4, the downswing of the prevalence
rate is preceded by a sharp increase in prevention, from zero to positive levels. As the econ-
omy slowly crawls out of poverty, prevalence rates remain high because prevention is too costly
and ineffective. Over time the economy accumulates enough capital to eventually afford some
prevention despite the high prevalence rate. With everyone investing in prevention, the cumu-
lative effect is to sharply reduce disease incidence. That prevention, however, extracts a cost as
the economy is still poor (low A): despite the higher average propensity to save, overall invest-
ment in capital suffers and the economy is left worse-off.10 This has the effect of discouraging
10Household saving is decreasing in x. In each example in Figures 3 and 4, the dip in the prevalence rate is
associated with a dip in output per worker. The cyclicality of output, however, depends on the assumption that
prevention is financially costly. It remains to be seen how other types of cost, such as utility loss, alter the nature
of these output cycles. Note also that we do not attempt to formally establish these results. This is because as
the economy cycles back and forth across the x(Kt , it ) = 0 locus, the discrete change in prevention introduces a
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future prevention, an effect amplified by the disease externality: as the prevalence rate drops,
the risk of contagion drops too, weakening the need for prevention at the margin. Prevention
efforts are scaled back, the economy recovers because more is allocated towards saving, and
infectious diseases rebound.
Stated differently, the interplay of the infection rate – the product of the exogenous con-
tact rate and endogenous susceptibility – and the cost of healthy behavior is what underlies the
cyclicality of health and output in the poverty trap. Susceptibility can be low or high depend-
ing on whether or not prevention is incentive compatible. Rational health behavior based on
prevalence alone may not cause cycles (see Philipson, 2000, section 3, for an illustration). A
complementarity between disease prevalence and economic conditions is necessary.
Note also that cycles do not exist when the second effect – how much diseases drag down
savings – is too weak or too strong. The effect is too weak for high TFP and low mortality cost
(values of φ and δ closer to one): even though ill health initially weighs growth down, the econ-
omy eventually rebounds and takes off. When the effect is too strong – low TFP and especially
high mortality cost as in CPP (2010) – we get a conventional poverty trap with monotonic con-
vergence.
4 Aiding a Health Transition
What is the cost of ill health in terms of lost growth? What is the best strategy to achieve good
health and high growth? Can foreign aid help? We turn to these questions next.
Our theory departs from the standard neoclassical model in two ways: there are externalities
in the production of goods and of health. Of these, health externalities are critical in depress-
ing economic activity and there may be a case to prioritize health in order to facilitate overall
development. With this in mind, we consider various types of transfers or subsidies. Some of
them subsidize health expenditure, others are unconditional cash transfers. We study the effec-
tiveness of each policy in facilitating growth and improving welfare. In conducting these exper-
iments, we ignore problems of implementation or institutional failures. The focus is simply on
the potential of these policies to make a difference.
discontinuity to the dynamical system. We leave a more formal analysis for future work.
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4.1 Conditional and Unconditional Transfers
An advantage of our model of poverty and underdevelopment is that it provides a setting to
study the tension between conditional and unconditional transfers. It is not income alone that
makes poverty persistent in the model, it is lack of incentives stemming from a high disease
burden. The public economics literature has traditionally preferred unconditional transfers to
conditional transfers: by giving individuals more choice the former can unequivocally improve
welfare relative to the latter. That conclusion rests on static models of poverty. If lack of incen-
tives keeps an economy mired in poverty over time, however, conditional transfers that target
those incentives can generate dynamic gains that unconditional transfers do not (Mookherjee,
2006).
We will study two targeted subsidies, or conditional cash transfers, directed towards health:
one is financed through foreign aid (x f ), and the other domestically funded (xd ) through lump-
sum taxation. In addition we study an unconditional cash transfer policy, a pure subsidy to
household income (w f ) funded by foreign aid. In other words, x f is tied foreign aid while w f is
untied.
Rewrite the decision problem of infected and uninfected individuals as
VUt ≡MaxzUt
[(
wt −τ+w f − zUt
)1−σ
1−σ +β
(
Rt+1zUt
)1−σ
1−σ
]
− 1+β
1−σ
and
V It ≡Maxz It
[[
(1−θ)wt −τ+w f − z It
]1−σ
1−σ +φβ
(
Rˆt+1z It
)1−σ
1−σ
]
− 1+φβ
1−σ
respectively, given xt and where τ is a lump sum tax. Health investment is chosen ex ante to
maximize expected lifetime utility
V (xt )≡ (1−pt )VUt (xt )+ptV It (xt )
subject to
pt = 1−
[
1− ai t
1+q(xt +xs)
]µ
given it and where xs ≥ 0, xs ∈ {x f ,xd }, is a transfer that can be used only towards health. Subsi-
dies crowd out private health expenditure but not entirely. Hence health outcomes can improve
with xs . As long as the household invests an amount in prevention larger than the subsidy,
whether this is given as an income transfer or as an equivalent amount of health aid does not
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matter. The health and financial aid bundles {(xs ,0), (0,w f )} with xs =w f both improve health
by the same magnitude as long as xt > xs . However, as we saw above, households do not always
want to invest in prevention. In that case, an unconditional transfer has no effect on health be-
havior while conditional aid, by forcing it to be used towards prevention, can make a difference
to health outcomes. The issue is if that health outcome makes a difference to social welfare.
For social welfare, we take a finite horizon social welfare function
Wt ≡
t+T∑
r=t
Vr (11)
whereVr is given by the expected utility function (under optimal xr ) above, that is, the weighted
average of the welfare of healthy and unhealthy individuals in generation r . We present results
for T = 10 by which time much of the transition dynamics is over. We report social welfare
effects relative to the non-intervention benchmark, noting that preferences are cardinal due to
lifetime uncertainty.
4.2 Engineering an early escape
Suppose that the economy is moving along the transitional path outlined by Figure 2(b). Fig-
ures 5, 6 and 7 illustrate the dynamics of income per worker, life expectancy and generational
welfare under different policy packages (xs ,w f ). In each case the amount of the subsidy per
generation is always 80 units, applied only for the first three generations. This subsidy amount
is chosen such that when it is tied to health investment, it exceeds what individuals would have
invested on their own.11 The five lines on each figure correspond to these scenarios: no subsi-
dies (black solid), domestically funded conditional transfers xd (grey dashed), conditional for-
eign aid x f (black dash-dotted), unconditional foreign aid w f (grey solid) and a combination
policy of x f for one generation followed by xd for two (grey dotted). In each figure, the hori-
zontal axis measures generational time, starting with the generation that first experiences the
policy, and policies are applied only during t = 1,2,3.
Two things are to be noted. First at full prevalence a domestic policy of tax and uncondi-
tional transfer would not alter outcomes since everyone is unhealthy. Hence we study domestic
11Health-based foreign aid in Africa has often followed a “vertical” versus “horizontal” approach (Easterly, 2009).
In the former, a specific disease has been targeted through information, vaccination and other preventive cam-
paigns, besides therapy. The latter focuses, instead, on improving the disbursement of health care through public
health reforms. Our analysis of health-based interventions avoids the horizontal approach since we do not for-
malize the public health system or its shortcomings. At the same time, we do not look at interventions focused on
a particular disease like malaria or HIV/AIDS.
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Figure 5: Output Growth per Generation under Alternative Policies
conditional transfers alone. Secondly, the combination policy package is meant to capture an
emerging view that, given problems of aid dependence, foreign aid ought to be used as a tem-
porary tool. For example, Ranis (2012) argues that engineering economic development may
require unpalatable reforms. Rather than bearing the entire cost of that adjustment domesti-
cally, foreign aid may be used to ease the economy into the initial phase of adjustment before
domestic policies take over. In our combination policy, conditional foreign aid is provided to
the initial generation to encourage costly prevention and is then replaced by fully-funded do-
mestic conditional aid for two more generations.
As was noted earlier, under no subsidies, the economy initially experiences negative growth
and rebounds from the third generation. The “no subsidies” line in Figure 5 reflects the income
dynamics of Figure 2(b). Domestic conditional aid xd financed by taxes cannot accelerate the
process. This is because both health investment and capital accumulation contribute to take
the economy out of slow growth. When the economy allocates more resources to health by
taxing income, capital accumulation decelerates and this latter effect dominates the boost that
better health provides. Indeed, under this policy the economy experiences three generations
of negative growth due to over-investment in prevention, followed by low growth due to higher
prevalence than under “no subsidies”. In Figure 7, we see that this package gives the lowest
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utility of all policies.12
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Figure 6: Life Expectancy per Generation under Alternative Policies
Indeed Figure 5 makes it clear that the best policy to improve growth during the first three
generations is unconditional foreign aid w f followed by conditional foreign aid x f . By the
fourth generation, however, the latter starts to narrowly dominate. The only dimension in
which x f outperforms w s is in terms of longevity (Figure 6).
Figure 5 also shows that the combination policy of foreign and domestic conditional aid
is better than a pure domestic policy, but does come at a cost. Both x f and x f &xd generate
similar initial outcomes since they do not differ in the first period. But the pain of adjustment
due to higher taxes from the second generation decelerates capital accumulation. Growth falls
drastically (Figure 5) even as life expectancy improves (Figure 6).
How do these policies affect generational welfare? Figure 7 shows that unconditional foreign
aid is again the best while domestic unconditional transfers the worst. To net out the “short run”
effects from the “long run”, Table 2 reports social welfare calculations using (11). The first col-
umn of results shows that the gap in welfare improvements between x f and w f is not large but
reflects more the dynamics of income than of health. Both policies, though, clearly dominate
12We do not study domestic optimal policies for this reason. Any such policy would be dominated by one that
wholly or partly relies on foreign assistance.
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the alternatives.
σ= 1,A = 24.18 σ= 1.5,A = 43.32 σ= 1, i1 = 0.3 σ= 1,A = 24.18,K1 = 12 σ= 1,A = 20.5,K1 = 7
xd ↓ 7% ↓ 4.5% ↓ 15.0%
x f ↑ 58.7% ↑ 6.5% ↑ 14.2% ↑ 101.7% ↓ 0.44%
w f ↑ 61.3% ↑ 6.7% ↑ 14.5% ↑ 106.9% ↑ 1.72%
x f ,xd ↑ 27.3% ↓ 0.9% ↑ 33.9%
Table 2: Welfare Effects of Alternative Policies
As a robustness check, the second column of Table 2 reports social welfare under a lower EIS
but the same long-run growth rate of 1.8% per year. The relative ranking of unconditional and
conditional foreign aid remains unchanged although welfare changes are now smaller. Under a
lower EIS, households are less inclined to postpone consumption either through better health
or savings. Hence policies meant to improve income growth or future population health are
valued less.
Does policy effectiveness depend on initial conditions? We examine this by lowering the
initial prevalence rate to 30%. Welfare comparisons for the two types of foreign aid appear in
the fourth column of Table 2. The forces of convergence at this lower prevalence rate are, of
course, much stronger since the population is healthier. Since the prevalence rate is low, pre-
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vention is effective and high. Not surprisingly welfare improvements are smaller than the base-
line scenario and it remains true that foreign aid yields a higher payoff if it is directed towards
augmenting household budgets rather than health alone.
4.3 Policies in a Poverty Trap
Entertain now a scenario where conditional health aid has the potential to be especially im-
portant: a poverty trap. We will study two such traps. Start with the poverty trap cycle for the
baseline parameter values of Table 1 and initial conditions (K1, i1) = (12,1) for which output
fluctuates between 226 and 113. We apply the same policy packages, of 80 units during each of
three generations, to this economy. Social welfare effects are reported in the fourth column of
Table 2. The relative ranking of these policy alternatives is no different from the first column.
Surprisingly, unconditional aid still dominates conditional aid and, as expected, the welfare ef-
fects are significantly larger than for an economy already converging to high growth.
To assess the robustness of this result, suppose A = 20.5. Now potential long-run growth
is 1.27% annually and a poverty trap exists where the economy cycles between output levels
of 133 and 196. Suppose the economy starts at (K1, i1) = (7,1), inside the poverty trap at an
income level just above the lower bound of the cycle. If subsidies are sufficiently large to get
the economy immediately out of the trap, there is no difference in outcomes between x f and
w f . Hence we use a lower subsidy amount than before, 15 units, applied for three generations.
Welfare comparisons between conditional and unconditional foreign aid is reported in the last
column of Table 2. Here too unconditional aid dominates conditional aid and welfare changes
are much smaller than in the baseline scenario. The negative effect of conditional aid is due to
the fact that, since income levels are now lower, incentivizing healthy behavior is more costly
as it shifts resources away from capital accumulation.
In all the cases we studied above, the economy is initially very poor. At such low levels of
income, the marginal utility of consumption is high, which means even a little income growth
substantially improves welfare. Even though x f improves longevity by more and lowers mor-
bidity, the income growth effect from w f dominates overall welfare calculations. This result
bears upon the convergence of living standards around the world. Even though income levels
around the world have not converged much since WWII, life expectancy at birth has. By in-
corporating an income equivalent of these life expectancy improvements, Becker et al. (2005)
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show that this “full income” has converged much faster across countries than conventionally
measured income. The welfare calculations above suggest that, despite the remarkable gains
in life expectancy, income growth contributes to welfare convergence more strongly. In other
words, all else equal, the marginal dollar is better invested in improving income in poorer coun-
tries than health. This result is, of course, sensitive to the parameterization. For some African
countries the cost of ill health may well be more substantial than Table 1 in which case health-
based assistance would yield larger welfare gains.
In conclusion we note that our policy experiments suggest that, in principle, foreign assis-
tance can be an effective way to improve income and health in the poorest regions. Despite ill
health being the root of poverty here, conditional aid targeted towards healthy behavior does
not dominate unconditional aid. The former does improve population health significantly but
the income gains from the latter dominate welfare calculations. While the welfare gap between
conditional and unconditional aid is not large, it is consistently positive across these experi-
ments. Both types of policies dominate purely domestic or combination policies because of the
distortionary effect of taxes on capital accumulation.
5 Conclusions
This paper has presented new theoretical results on the presence of disease cycles in an eco-
nomic model of epidemiology. Based on the broad patterns of sub-Saharan Africa’s economic
development, it has also quantitatively assessed whether and how policy can accelerate growth,
eliminate the burden of ill health and improve overall welfare in the developing world. For
both purposes, we use a modified version of the general equilibrium model of infectious dis-
ease transmission and economic growth presented in Chakraborty et al. (2010). The model is
sufficiently simple to clearly point out important policy trade-offs, but at the same time rich
enough to capture the main features of sub-Saharan Africa’s disease ecology and development
challenges. In future research we hope to incorporate more precise demographic structure and
health behavior to understand the applicability of these results for development policymaking
and the control of infectious diseases.
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